Domov › Areata alopecija › Kalifornija
Klinične študije za Areata alopecija v Kalifornija
10 študij za Areata alopecija išče udeležence na lokacijah v Kalifornija.
Mesta v Kalifornija
Uradno besedilo študije (angleško)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dermatology Research Associates - Los Angeles /ID# 282821, Los Angeles
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Center For Dermatology Clinical Research, Inc., Fremont
- Northridge Clinical Trials, Northridge
- Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway, Santa Clarita
Vključevanje udeležencevFaza 2
Starost 18–50 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Doc1 Healthcare Systems, Brea
- University of California - Irvine, Irvine
- Gavin Herbert Eye Institute, Irvine
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- California Dermatology & Clinical Research Institute, Encinitas
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07733765Dupilumab in the Treatment of Pediatric Alopecia Areata
- University of California, Irvine, Irvine
- University of California San Diego, San Diego
Vključevanje udeležencevFaza 2
Starost 6–17 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT05866562A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Exalt Clinical Research /ID# 283814, Chula Vista
- First Oc Dermatology /ID# 259220, Fountain Valley
- Dermatology Research Associates /ID# 258033, Los Angeles
- in še 3
Vključevanje udeležencevFaza 3
Starost 12–63 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06012240Regeneron AA Multicenter (Dupilumab)
- University of California, Irvine, Irvine
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT05551793A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- California Dermatology & Clinical Research Institute, Encinitas
Vključevanje udeležencevFaza 3
Starost 6–14 · Vsi spoli · Posodobljeno 28. apr. 2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
- Clinical Trial Research Institute, Thousand Oaks
Vključevanje udeležencevFaza 1/2
Starost 18–55 · Vsi spoli · Posodobljeno 4. mar. 2026 · NCT06826196Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Kern Research Inc., Bakersfield
- Center For Dermatology Clinical Research Inc., Fremont
- Dermatology Research Associates, Los Angeles
- in še 2
Vključevanje udeležencevFaza 3
Starost 12–17 · Vsi spoli · Posodobljeno 28. jan. 2026 · NCT07133308Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.